Sanofi - Sanofi successfully prices EUR 2.0 billion bond issueOREANDA-NEWS. Sanofi announces that it has successfully priced its offering of EUR 2.0 billion of notes across 3 tranches:
  • EUR 750 million Floating Rate Notes, due 2019, bearing interest at a quarterly rate of 3-month Euribor + 0.30%
  • EUR 500 million Fixed Rate Notes, due 2021, bearing interest at an annual rate of 0.875%
  • EUR 750 million Fixed Rate Notes, due 2025, bearing interest at an annual rate of 1.500%

The issue is drawn under the Company's Euro Medium Term Note Programme.

The transaction enables the Group to lower its average cost of debt and extend the average maturity of its debt.

Sanofi intends to use the net proceeds of the offering for general corporate purposes, including the repayment of existing borrowings.

Bank of America - Merrill Lynch, HSBC, Soci?t? G?n?rale CIB, and Unicredit were Bookrunners for the offering.

About Sanofi

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).